Skip to main content
Caplight Logo









PD Neurotechnology

PD Neurotechnology

Private
AthensHealthcare & Life Scienceshttps://www.pdneurotechnology.com/

Last Round

Series A

Apr 25, 2023

Est. Valuation

$38.1M

Total Funding Raised

$9.39M

Company Overview

PD Neurotechnology is a medical technology company that develops wearable medical devices and digital health solutions for the continuous monitoring and treatment of Parkinson's disease and other movement disorders.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Healthcare Analytics, Patient Engagement

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales

AI Layer

Application

Keywords

Parkinson's monitoringwearable medical devicedigital healthremote patient monitoringRPMclinical decision supportmovement disorderhealth IoTmedical wearabledigital biomarkertelemedicinehealthcare analyticsconnected healthpatient engagementmHealth

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PD Neurotechnology Comparables

Compare PD Neurotechnology with similar companies based on industry and business-model similarity.

PD Neurotechnology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sense4Care
87%
Great Lakes NeuroTechnologies Inc.
84%
SERG Technologies
83%

PD Neurotechnology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AApr 25, 2023
SeedNov 15, 2019

PD Neurotechnology Investors

Notable investors and investment history

PD Neurotechnology investors
InvestorRounds
Onassis FoundationSeries A, Seed
National Bank of GreeceSeries A
SeedBlinkSeries A
Crimson International InvestmentSeries A
Big Pi VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 1, 2025

    Monthly visitors grew 43% MoM, from 700 to 1K.

  • Oct 29, 2024

    Monthly visitors grew 248% MoM, reaching 801.

PD Neurotechnology Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

PD Neurotechnology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about PD Neurotechnology's valuation, stock price, and market status.

Firmographic Details

HeadquartersAthens
Employee Range24
Year Founded2015
Last FundingApr 25, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?